Fruth Investment Management Lowers stake in Agilent Technologies Inc (A)

Agilent Technologies Inc (A) : Fruth Investment Management reduced its stake in Agilent Technologies Inc by 1.3% during the most recent quarter end. The investment management company now holds a total of 53,125 shares of Agilent Technologies Inc which is valued at $2,427,281 after selling 700 shares in Agilent Technologies Inc , the firm said in a disclosure report filed with the SEC on Oct 12, 2016.Agilent Technologies Inc makes up approximately 1.23% of Fruth Investment Management’s portfolio.

Other Hedge Funds, Including , Fox Run Management L.l.c. reduced its stake in A by selling 8,800 shares or 64.23% in the most recent quarter. The Hedge Fund company now holds 4,900 shares of A which is valued at $223,881. Agilent Technologies Inc makes up approx 0.13% of Fox Run Management L.l.c.’s portfolio.Independent Portfolio Consultants reduced its stake in A by selling 2,030 shares or 70.61% in the most recent quarter. The Hedge Fund company now holds 845 shares of A which is valued at $39,842. Agilent Technologies Inc makes up approx 0.01% of Independent Portfolio Consultants’s portfolio. Eqis Capital Management added A to its portfolio by purchasing 4,475 company shares during the most recent quarter which is valued at $210,996. Agilent Technologies Inc makes up approx 0.01% of Eqis Capital Management’s portfolio.

Agilent Technologies Inc closed down -2 points or -4.19% at $45.69 with 29,12,537 shares getting traded on Tuesday. Post opening the session at $47.19, the shares hit an intraday low of $45.42 and an intraday high of $47.19 and the price fluctuated in this range throughout the day.Shares ended Tuesday session in Red.

On the company’s financial health, Agilent Technologies Inc reported $0.49 EPS for the quarter, beating the analyst consensus estimate by $ 0.02 according to the earnings call on Aug 17, 2016. Analyst had a consensus of $0.47. The company had revenue of $1044.00 million for the quarter, compared to analysts expectations of $1046.16 million. The company’s revenue was up 3.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.44 EPS.

Agilent Technologies Inc. is engaged in the life sciences diagnostics and applied chemical markets. The Company provides application focused solutions that include instruments software services and consumables for the entire laboratory workflow. The Company has three business segments: the life sciences and applied markets business the diagnostics and genomics business and the Agilent CrossLab business. The Company’s life sciences and applied markets business segment brings together the Company’s analytical laboratory instrumentation and informatics. The Company’s diagnostics and genomics business segment consists of three businesses: the Dako business the genomics business and the nucleic acid solutions business. The Company’s Agilent CrossLab business segment combines its analytical laboratory services and consumables business.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Agilent Technologies Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on Agilent Technologies Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.